Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6NCya-Asf1bem1/Cya
Common Name:
Asf1b-KO
Product ID:
S-KO-11999
Background:
C57BL/6NCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Asf1b-KO
Strain ID
KOCMP-66929-Asf1b-B6N-VA
Gene Name
Asf1b
Product ID
S-KO-11999
Gene Alias
1700003K02Rik; CIA-II
Background
C57BL/6NCya
NCBI ID
66929
Modification
Conventional knockout
Chromosome
8
Phenotype
MGI:1914179
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6NCya-Asf1bem1/Cya mice (Catalog S-KO-11999) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000005607
NCBI RefSeq
NM_024184
Target Region
Exon 2~4
Size of Effective Region
~5.2 kb
Detailed Document
Click here to download >>
Overview of Gene Research
Asf1b, the Anti-silencing Function of 1B histone chaperone, is crucial for S-phase progression and cell proliferation [7,9]. It was originally discovered in yeast as a histone H3-H4 chaperone. As a histone chaperone, it is involved in nucleosome assembly during DNA replication, thus participating in pathways related to the cell cycle, DNA repair, and chromatin regulation [5,8,9]. Its normal function is essential for maintaining proper cell growth and division, and understanding its role is important for exploring cell biological processes and disease mechanisms.

In multiple cancer types, Asf1b has been found to play significant roles. In hepatocellular carcinoma (HCC), it is highly expressed, and its high expression is associated with tumor grade, race, disease stage, and poor overall and progression-free survival. Knockdown of Asf1b inhibits HCC cell proliferation, induces apoptosis and cell cycle arrest, suggesting it promotes HCC development [2,7,9]. In stomach adenocarcinoma (STAD), Asf1b is also upregulated, and high expression indicates poor survival. Functional enrichment analysis shows its related genes are enriched in the cell cycle and DNA repair pathways [1]. In cervical cancer, Asf1b functions as an oncogene, and its silence suppresses cancer cell growth in vitro and in vivo [3]. In gliomas, increased Asf1b expression is linked to poor prognosis, and it is associated with nuclear division, cell cycle, and related checkpoints [4]. In gastric cancer, Asf1b is upregulated, correlates with TNM stage, histological grade and poor prognosis, and promotes cell proliferation, migration and invasion [5,8]. In lung adenocarcinoma, knocking down Asf1b impairs cell proliferation, affects cell cycle distribution and induces apoptosis [6].

In conclusion, Asf1b is a key histone chaperone involved in cell cycle-related processes. Its overexpression in various cancers such as HCC, STAD, cervical cancer, gliomas, gastric cancer, and lung adenocarcinoma promotes tumor progression, as revealed by knockdown experiments. Understanding the role of Asf1b through such functional studies provides insights into cancer development mechanisms, suggesting it could be a potential therapeutic target for these cancers.

References:

1. Zhao, Cailing, Zhou, Jianghao, Xing, Jianwei, Yin, Qiushi. . ASF1B acted as a prognostic biomarker for stomach adenocarcinoma. In Medicine, 102, e35408. doi:10.1097/MD.0000000000035408. https://pubmed.ncbi.nlm.nih.gov/38050219/

2. Li, Renzhi, Cui, Xiaohan, Sun, Weijun, Shen, Xingyuan, Zhu, Chunfu. . ASF1B, as an Independent Prognostic Biomarker, Correlates with Immune Infiltrates in Hepatocellular Carcinoma. In Combinatorial chemistry & high throughput screening, 26, 1311-1323. doi:10.2174/1386207325666220820112111. https://pubmed.ncbi.nlm.nih.gov/35993469/

3. Liu, Xinjian, Song, Jingwei, Zhang, Yenan, Tang, Qi, Ji, Minjun. 2020. ASF1B promotes cervical cancer progression through stabilization of CDK9. In Cell death & disease, 11, 705. doi:10.1038/s41419-020-02872-5. https://pubmed.ncbi.nlm.nih.gov/32848135/

4. Zhu, Huaxin, Ouyang, Hengyang, Pan, Xinyi, Li, Meihua, Zhao, Yeyu. 2022. Increased ASF1B Expression Correlates With Poor Prognosis in Patients With Gliomas. In Frontiers in oncology, 12, 912101. doi:10.3389/fonc.2022.912101. https://pubmed.ncbi.nlm.nih.gov/35875094/

5. Zhao, Zhou, Cai, Zhaolun, Zhang, Su, Han, Junhong, Zhang, Bo. 2024. Activation of the FOXM1/ASF1B/PRDX3 axis confers hyperproliferative and antioxidative stress reactivity to gastric cancer. In Cancer letters, 589, 216796. doi:10.1016/j.canlet.2024.216796. https://pubmed.ncbi.nlm.nih.gov/38537775/

6. Zhang, Wencheng, Gao, Zhouyong, Guan, Mingxiu, Meng, Fanjie, Wang, Guangshun. 2021. ASF1B Promotes Oncogenesis in Lung Adenocarcinoma and Other Cancer Types. In Frontiers in oncology, 11, 731547. doi:10.3389/fonc.2021.731547. https://pubmed.ncbi.nlm.nih.gov/34568067/

7. Zhang, Shirong, Xu, Longwen, Feng, Jinteng, Jiao, Min, Guo, Hui. 2022. ASF1B is a Promising Prognostic Biomarker and Correlates With Immunotherapy Efficacy in Hepatocellular Carcinoma. In Frontiers in genetics, 13, 842351. doi:10.3389/fgene.2022.842351. https://pubmed.ncbi.nlm.nih.gov/35360875/

8. Chen, Chuanzhi, Bao, Haili, Lin, Wu, Lv, Xiadong, Teng, Lisong. 2022. ASF1b is a novel prognostic predictor associated with cell cycle signaling pathway in gastric cancer. In Journal of Cancer, 13, 1985-2000. doi:10.7150/jca.69544. https://pubmed.ncbi.nlm.nih.gov/35399734/

9. Ouyang, Xiaoxi, Lv, Longxian, Zhao, Yalei, Zhu, Danhua, Li, Lanjuan. 2022. ASF1B Serves as a Potential Therapeutic Target by Influencing Cell Cycle and Proliferation in Hepatocellular Carcinoma. In Frontiers in oncology, 11, 801506. doi:10.3389/fonc.2021.801506. https://pubmed.ncbi.nlm.nih.gov/35087760/

Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest